GliaCure Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:GliaCure Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11195
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
GliaCure Inc (GliaCure) is a developer of novel therapies for neurological and neuropsychiatric disorders. The company uses glia as an untapped resource for drug discovery, which controls the brain function in health and disease. It develops small molecule pharmaceuticals for the treatment of Alzheimer’s disease. GliaCure offers glia-targeted medicines to treat other disorders that include traumatic brain injury, down syndrome, parkinson’s disease, glioblastoma, neuropathic pain, epilepsy, psychiatric and sleep disorders. The company builds its existing discoveries on the role of astrocytes as a critical conduit for mediating fast-acting antidepressive effects. GliaCure is headquartered in Boston, Massachusetts, the US.

GliaCure Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
GliaCure Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
GliaCure Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
GliaCure Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
GliaCure Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
GliaCure Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
GliaCure Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
GliaCure Raises USD1.6 Million in Venture Financing 10
GliaCure Raises USD5.8 Million in Series B Financing 11
GliaCure Raises USD3 Million in Venture Financing 12
Gliacure Raises Additional US$1.8 Million In Venture Financing 13
Licensing Agreements 14
GliaCure Enters into Licensing Agreement with Tufts University 14
GliaCure Inc – Key Competitors 15
GliaCure Inc – Key Employees 16
GliaCure Inc – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
GliaCure Inc, Pharmaceuticals & Healthcare, Key Facts 2
GliaCure Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
GliaCure Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
GliaCure Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
GliaCure Inc, Deals By Therapy Area, 2012 to YTD 2018 8
GliaCure Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
GliaCure Raises USD1.6 Million in Venture Financing 10
GliaCure Raises USD5.8 Million in Series B Financing 11
GliaCure Raises USD3 Million in Venture Financing 12
Gliacure Raises Additional US$1.8 Million In Venture Financing 13
GliaCure Enters into Licensing Agreement with Tufts University 14
GliaCure Inc, Key Competitors 15
GliaCure Inc, Key Employees 16

List of Figures
GliaCure Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
GliaCure Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
GliaCure Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
GliaCure Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
GliaCure Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
GliaCure Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
GliaCure Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
GliaCure Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[GliaCure Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mirage Retail Group BV:企業の戦略的SWOT分析
    Mirage Retail Group BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Hays plc:企業の戦略・SWOT・財務情報
    Hays plc - Strategy, SWOT and Corporate Finance Report Summary Hays plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Tennessee Valley Authority:企業の戦略・SWOT・財務情報
    Tennessee Valley Authority - Strategy, SWOT and Corporate Finance Report Summary Tennessee Valley Authority - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Shoal Point Energy Ltd (SHP):石油・ガス:M&Aディール及び事業提携情報
    Summary Shoal Point Energy Ltd (Shoal Point Energy) is an oil and gas exploration and development company that acquires, develops, explores, and produces petroleum products. The company holds interests in Green Point Oil-in-Shale and Humber Arm Shale project. It also holds interests in the explorati …
  • ADInstruments Pty Ltd:企業の戦略的SWOT分析
    ADInstruments Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Louisiana-Pacific Corporation:戦略・SWOT・企業財務分析
    Louisiana-Pacific Corporation - Strategy, SWOT and Corporate Finance Report Summary Louisiana-Pacific Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • China Overseas Land & Investment Limited:企業の戦略・SWOT・財務情報
    China Overseas Land & Investment Limited - Strategy, SWOT and Corporate Finance Report Summary China Overseas Land & Investment Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Wegmans Food Markets Inc:企業の戦略的SWOT分析
    Wegmans Food Markets Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Elong Inc:企業の戦略・SWOT・財務分析
    Elong Inc - Strategy, SWOT and Corporate Finance Report Summary Elong Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • TomTom NV (TOM2):企業の財務・戦略的SWOT分析
    TomTom NV (TOM2) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • SoftBank Group Corporation:企業のM&A・事業提携・投資動向
    SoftBank Group Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SoftBank Group Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Itausa – Investimentos Itau SA (ITSA4):企業の財務・戦略的SWOT分析
    Itausa - Investimentos Itau SA (ITSA4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Sensus Healthcare Inc (SRTS):企業の財務・戦略的SWOT分析
    Sensus Healthcare Inc (SRTS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Caladrius Biosciences Inc (CLBS):医療機器:M&Aディール及び事業提携情報
    Summary Caladrius Biosciences Inc (Caladrius), formerly NeoStem Inc, is a clinical-stage biopharmaceutical company that develops cell therapy products. The company offers multiple technology platforms targeting cardiovascular indications and autoimmune diseases. The company’s lead product CLBS03 is …
  • Sompo Japan Nipponkoa Holdings, Inc.:企業の戦略・SWOT・財務情報
    Sompo Japan Nipponkoa Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sompo Japan Nipponkoa Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Virgin Islands Water and Power Authority:企業の戦略的SWOT分析
    Virgin Islands Water and Power Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Biolife Solutions Inc (BLFS):企業の財務・戦略的SWOT分析
    Summary Biolife Solutions Inc (BioLife Solutions) is a developer, manufacturer and supplier of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media for cells and tissues. The company offers serum-free and protein-free solutions, which are formulated to red …
  • Murad LLC:企業の戦略・SWOT・財務分析
    Murad LLC - Strategy, SWOT and Corporate Finance Report Summary Murad LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Grid2020, Inc.:電力:M&Aディール及び事業提携情報
    Summary Grid2020, Inc. (Grid2020) is a provider of smart grid solutions. The company offers an integrated distribution transformer monitoring solutions under the brand Optanode. The Optanode product family consists of sensors and smart analytics software and provides information about the distributi …
  • Taikisha Ltd
    Taikisha Ltd - Strategy, SWOT and Corporate Finance Report Summary Taikisha Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆